@article{e1e0af3fd8b34800a2c01431ce750ad4,
title = "CRASH-2 (Clinical Randomisation of an Antifibrinolytic in Significant Haemorrhage) intracranial bleeding study: the effect of tranexamic acid in traumatic brain injury--a nested randomised, placebo-controlled trial",
abstract = "Tranexamic acid (TXA) has been shown to reduce blood loss in surgical patients and the risk of death in patients with traumatic bleeding, with no apparent increase in vascular occlusive events. These findings raise the possibility that it might also be effective in traumatic brain injury (TBI).",
author = "P Perel and Salman, {R Al-Shahi} and T Kawahara and Z Morris and D Prieto-Merino and I Roberts and P Sandercock and H Shakur and J Wardlaw",
year = "2012",
doi = "10.3310/hta16130",
language = "English",
volume = "16",
pages = "iii--xii, 1--54",
journal = "Health Technology Assessment",
issn = "1366-5278",
publisher = "NIHR Health Technology Assessment Programme",
number = "13",
}